Brain Bioenergetics in Parkinson's Disease and Response to Repeated Oral UDCA Treatment
NCT02967250
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
ursodeoxycholic acid
Sponsor
University of Minnesota